TrialDiabetes care2012

Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes and renal impairment: the FIELD Study.

Ru-Dee Ting et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.